<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01086124</url>
  </required_header>
  <id_info>
    <org_study_id>10-010</org_study_id>
    <nct_id>NCT01086124</nct_id>
  </id_info>
  <brief_title>Objective Systolic Function Recuperation Assessed by Echocardiography</brief_title>
  <acronym>ROSE</acronym>
  <official_title>Objective Systolic Function Recuperation Assessed by Echocardiography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Paul Farand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université de Sherbrooke</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate left ventricular systolic ejection fraction and
      anterior or apical akinesis 1 month and 3 months after a myocardial infarction treated with
      primary PCI to determine whether improvement at 1 month differs from improvement at 3 months.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular ejection fraction recuperation 1 month post myocardial infarction</measure>
    <time_frame>1 month post myocardial infarction</time_frame>
    <description>Left ventricular ejection fraction recuperation 1 month post myocardial infarction as compared with the left ejection fraction 3 months post myocardial infarction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anterior and apical akinesis recuperation 1 month post myocardial infarction</measure>
    <time_frame>1 month post myocardial infarction</time_frame>
    <description>Anterior and apical akinesis recuperation 1 month post myocardial infarction as compared with 3 months post myocardial infarction</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">42</enrollment>
  <condition>Myocardial Infarction</condition>
  <condition>Left Ventricular Systolic Dysfunction</condition>
  <condition>Anterior Akinesis</condition>
  <condition>Apical Akinesis</condition>
  <arm_group>
    <arm_group_label>Echocardiography 1 month</arm_group_label>
    <description>Patients will all have an echocardiography 1 month post myocardial infarction and 3 months post myocardial infarction</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting to teaching hospital or sent from community hopitals to teaching
        hospital for primary PCI
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Older than 18 years old

          -  ST elevation myocardial infarction treated with primary PCI

          -  Anterior or apical akinesis and left ventricular ejection fraction ≤ 45% on early
             echocardiography (48hours - 7 days post myocardial infarction)

          -  Initial ECG showing at least 1 mm ST elevation in 2 leads corresponding to the same
             vascular territory

        Exclusion Criteria:

          -  Known left ventricular systolic dysfunction before myocardial infarction

          -  Left bundle branch block

          -  Vital prognosis less than 6 months

          -  Cardiogenic shock

          -  Rescue PCI

          -  Sub-optimal echocardiographic imaging (contrast use is allowed)

          -  Significant valvular heart disease (moderate or severe)

          -  Surgical revascularization

          -  Pregnancy or breastfeeding

          -  Incapacity to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Farand, md</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de recherche du Centre hospitalier universitaire de Sherbrooke</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre hospitalier universitaire de Sherbrooke</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 11, 2010</study_first_submitted>
  <study_first_submitted_qc>March 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2010</study_first_posted>
  <last_update_submitted>July 3, 2013</last_update_submitted>
  <last_update_submitted_qc>July 3, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Université de Sherbrooke</investigator_affiliation>
    <investigator_full_name>Paul Farand</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>echocardiography</keyword>
  <keyword>ST elevation myocardial infarction</keyword>
  <keyword>Heart failure</keyword>
  <keyword>Coronary artery disease</keyword>
  <keyword>Cardiovascular diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Ventricular Dysfunction, Left</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

